Replies to post #358909 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Yes, I agree. It was that plus this current information that is now showing on UCLA's own website. The truth hurts, especially if it is not consistent with the false narrative they are trying to promote.

It is very telling that on this website page, UCLA lists the only 2 current immunotherapy treatment options currently available at UCLA for brain cancer as: DCVax-L & PD-1 inhibitors.

Especially, considering that the only current open clinical trial, that is currently recruiting at UCLA for recurrent Glioblastoma, is ATL-DC (DCVax-L) plus Pembrolizumab (Keytruda).

It is all so plain to see, unless you refuse to see it, as some Bears on this board have chosen not to see this.

https://www.uclahealth.org/braintumor/biologics

[ahp123]

you might be right .. but there are also the possibility that they just seem more desperate because people themselves deep down have become a little insecure, and the statements bears come up with are the same as it has been for years, but just have a different effect on longs due to the uncertainty. I'm not saying that is the case, but it could be....
and you can ask yourself who is most desperate, those who question the outcome or those who do not question it and do not accept that there is a risk that data may not be good enough for an approval ..